|
Ellen R. Hoffing has been President Chief Executive Officer and a Director since August 29 2006. Since 2005 she has been a consultant to healthcare focused companies. In 2005 Ms. Hoffing was Vice President Strategic Planning at American Pharmaceutical Partners a publicly traded specialty pharmaceutical company focused on injectable oncology anti-infective and critical care products. From 2002 to 2005 Ms. Hoffing was Vice President Renal Pharmaceuticals at Baxter Healthcare a New York Stock Exchange listed company. From 2001 to 2002 she was Vice President Strategy and Acquisitions at Merisant (the maker of Equal®) and from 2000 to 2001 Ms. Hoffing was a strategy and management consultant to healthcare focused companies. Prior to 2000 Ms. Hoffing took on roles of increasing responsibility in her 17 years at the Searle division of Monsanto which culminated in her position as Vice President Global Analytics. | 